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http://dx.doi.org/10.1016/j.kjms.201Abstract The risks of surgery and its clinical outcome are of great importance for both
patients and physicians when choosing coronary artery bypass (CABG) surgery for coronary
artery disease. The purpose of the current study was to clarify the relationship between serum
B-type natriuretic peptide (BNP) and patient clinical outcome. Seventy-six eligible patients
who underwent CABG were enrolled into the prospective study. Venous blood samples were
drawn for serum BNP and N-terminal (NT)-proBNP levels measurement on preoperative Day
1, postoperative Day 1, and postoperative Day 7. Clinical end points were: (1) intensive care
unit (ICU) stay longer than 4 days postoperatively and/or hospital stay longer than 13 days
postoperatively; (2) major complications and poor outcomes. Patients who had prolonged
ICU stay and hospitalization had significantly higher postoperative Day 1 BNP and postoperative
Day 1 NT-proBNP level (p Z 0.02 and 0.005, respectively). Age was significantly older in
patients with prolonged ICU stay and hospitalization than those without prolonged ICU stay
and hospitalization (p Z 0.03). Serum creatinine level was also significantly increased in
patients with prolonged ICU stay and hospitalization (p Z 0.009). However, age was the only
remaining factor that correlated with prolonged ICU stay and hospitalization in the multivar-
iate logistic regression model. These results suggest that research using BNP and NT-proBNP
for predicting ICU stay and hospitalization in patients who have undergone CABG must adjust
risk factors to present a more appropriate estimation of its clinical outcome.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Cardiology, Department of
280, Section 4, Ren-Ai Road
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Coronary artery disease is currently the major cause of
cardiovascular-related death in the modern world as well ased by Elsevier Taiwan LLC. All rights reserved.
Risk factors and BNP in CABG 255in developing countries [1]. The cost of coronary artery
bypass graft (CABG) surgery has been rising, making
a review of outcome and cost-effectiveness imperative.
Among major adverse events, prolonged hospitalization
and/or prolonged intensive care unit (ICU) stay are the
most common causes of costly medical expenses other than
death related to surgery. It is known that there are many
factors that can affect the outcome. Therefore, preoper-
ative factors have been grouped into a scoring system to
predict the possible risk of surgical mortality and morbidity
[2e4]. However, there is no gold standard prediction model
for length of hospital stay, surgical complications, and
outcomes [5]. Furthermore, scoring systems are often
cumbersome, which means an additional predicting system
is necessary. The B-type natriuretic peptide (BNP) is
a neurohormone mainly secreted from cardiac ventricles by
increasing ventricular wall stress and volume expansion [6].
There are several previous studies that demonstrated that
serum BNP concentration significantly increased after CABG
surgery and was associated with increasing postoperative
mortality and cardiac events [7,8]. Furthermore, ProBNP,
a serum protein comprising 108 amino acids, can be cleaved
into physiologically active BNP and biologically inactive N-
terminal proBNP (NT-proBNP), whose plasma concentration
reflects the activity of de novo synthesis and may have even
greater specificity to cardiac activity than BNP [9]. NT-
proBNP is also more stable, which makes its measurement
more reliable [10]. Studies demonstrated that NT-proBNP
can be used in diagnosing left ventricular dysfunction and
acute coronary syndrome [11,12]. Theoretically, the
elevation of serum NT-proBNP concentration may also
reflect the higher mortality and complication rates after
CABG surgery. However, there were studies suggesting that
several variables of general population such as female sex,
old age, and impaired renal function were also significantly
associated with higher BNP and NT-proBNP levels [9,13].
The variables may possibly affect the predictability by BNP
and NT-proBNP levels alone. Therefore, the purposes of the
current study are to assess whether BNP and NT-proBNP are
correlated with postoperative complications and outcomes
after adjusting for risk factors.Methods
The study was first reviewed and approved by the hospital’s
ethics committee, and then written informed consent was
obtained from each patient. Ninety-four patients who
underwent CABG surgery of a single surgeon were enrolled
into the prospective study between January 2006 and June
2007. Among the 94 patients, 10 patients with uremia, five
patients with inappropriate sample collection, and three
patients who underwent emergency operation were
excluded from the study. The remaining 76 patients all
received elective cardiac bypass surgery, including
conventional CABG surgery (single aortic cross-clamping,
deep hypothermia 23e25C, and crystalloid cardioplegia) in
54 patients, off-pump CABG surgery (median sternotomy,
normothermia) in 11 patients, and minimally invasive direct
CABG surgery (lateral thoracotomy with short segment of
5th rib resection) in 11 patients. Left ventricular ejection
fractions (LVEFs) were measured by echocardiography onpreoperative Day 1 and postoperative Day 7. The serum BNP
and NT-proBNP levels were measured on preoperative 1
Day, postoperative Day 1, and postoperative Day 7. Venous
blood samples were drawn for BNP and NT-proBNP analysis
after patients rested for 30 minutes. The venous samples
were placed into chilled ethylenediaminetetraacetic acid
tubes and placed on ice. After centrifugation, the plasma
samples were stored at 80C until assay. During the
procedure, Roche Elecsys, Roche Diagnostics, Indianapolis
1010/2010 kits and Modular analytics, Roche Diagnostics,
Indianapolis E170 immunoassay analyzers were used for the
quantitative determination of NT-proBNP. The Abbott
AxSYM (R), Abbott Laboratories, Illinois automated immu-
noassay instrument system was used for BNP measurement.
All data were collected afterward.
Clinical end points were: (1) ICU stay longer than 4 days
postoperatively and/or hospital stay longer than 13 days
postoperatively; (2) major complications and poor
outcomes, including new-onset atrial fibrillation, ventric-
ular tachycardia, ventricular fibrillation, requirement of
intra-aortic balloon pump (IABP) support, unscheduled
cardiac-related readmission to the hospital, and late
cardiac mortality within 1 year.
Data were analyzed using SPSS software (version 11.0.0,
SPSS Inc., Chicago, IL, USA) and expressed as the mean with
standard deviation. Categorical variables were presented
as counts and percentages. The student t test and c2 test
were used to examine differences in continuous and cate-
gorical variables, respectively. Multivariate logistic regres-
sion analyses were used to calculate odds ratios and 95%
confidence intervals, with adjustment for potential
confounders such as age, sex, creatinine level, heart failure
class, NYHA, and LVEF. A value of p < 0.05 was considered
statistically significant.Results
Patients’ mean age was 64.0  10.2 years, and 85.5% were
male. There were 5% of patients with preoperative New
York Heart Association functional class III or IV. Most
patients (76.3%) had triple vessel disease or left main
disease. The mean serum creatinine level was
1.2  0.38 mg/dL. The mean LVEF was 61.0  11.2 in
preoperative evaluation and 61.6  9.5 in postoperative
examination. There were no significant differences
between preoperative and postoperative LVEF (p Z 0.52).
Thirty-day surgical mortality and in-hospital mortality was
zero.
Fig. 1 shows the BNP and NT-proBNP changes. The mean
BNP was 103.8  184.0 pg/mL, 361.9  463.7 pg/mL, and
261.9  402.4 pg/mL at preoperation, postoperative Day 1,
and postoperative Day 7, respectively. There were signifi-
cant differences between preoperative BNP and post-
operative Day 1 BNP (p < 0.001), and, preoperative BNP and
postoperative Day 7 BNP (pZ 0.001). The mean NT-proBNP
was 621.3  1050.7 pg/mL, 2869.8  3252.6 pg/mL, and
1358.5  1632.3 pg/mL at preoperation, postoperative Day
1, and postoperative Day 7, respectively. The postoperative
Day 1 and Day 7 NT-proBNP concentrations were signifi-
cantly higher than preoperative NT-proBNP concentrations
(p < 0.001, respectively). Linear regression with 95%
Figure 1. Changes in B-type natriuretic peptide (BNP) and
NT-proBNP.
256 T.-H. Chen et al.individual prediction interval was used for the determina-
tion of the relationship between BNP and NT-proBNP
concentrations. The correlations between BNP and NT-
proBNP were all apparent at preoperation, postoperative
Day 1, and postoperative Day 7 (r Z 0.64, 0.84, and 0.89;
p < 0.001, respectively).
The values of BNP and NT-proBNP in on-pump and off-
pump CABG surgery are shown in Table 1. The BNP and NT-
proBNP concentrations were higher in on-pump CABG
surgery than those in off-pump CABG surgery. However,
there were no significant differences.
The mean ICU stay was 3.9  1.6 days and mean hospi-
talization was 12.8  4.9 days. There were 38 patients
staying in the ICU >4 days and/or admitted to hospital >13
days. IABP was administered in nine patients during surgery
due to unstable hemodynamic status. New-onset
arrhythmia occurred in three patients. A total of five
patients experienced readmission to the hospital and
mortality within 1 year, including one death and four
readmissions due to cardiac complications. Table 2 shows
BNP and NT-proBNP concentrations in patients with and
without clinical complications and outcomes. The post-
operative Day 1 NT-proBNP and postoperative Day 1 BNP
were significantly higher in patients with prolonged ICU stay
and hospitalization (p Z 0.03 and 0.01, respectively).
Preoperative BNP and preoperative NT-proBNP also were
higher with prolonged ICU stay and hospitalization.
However, there were no significant differences (p Z 0.34Table 1 The values of BNP and NT-proBNP in on-pump and off-
Coronary artery bypass surgery On-pump (
Preoperative BNP (pg/mL) 111.2 
Postoperative day 1 BNP (pg/mL) 373.1 
Postoperative day 7 BNP (pg/mL) 299.2 
Preoperative NT-proBNP (pg/mL) 663.7 
Postoperative day 1 NT-proBNP (pg/mL) 3132.2 
Postoperative day 7 NT-proBNP (pg/mL) 1520.1 
BNP Z B-type natriuretic peptide.and 0.12, respectively). Major complications and poor
outcomes included new-onset atrial fibrillation, ventricular
tachycardia, ventricular fibrillation, requirement of IABP
support, unscheduled cardiac-related readmission to the
hospital, and late cardiac-related mortality within 1 year.
Patients who suffered from major complications and poor
outcomes had higher preoperative BNP and NT-proBNP,
postoperative Day 1 BNP and NT-pro BNP, postoperative
Day 7 BNP and NT-proBNP concentrations. However, there
were no significant differences.
Table 3 presents patient characteristics with and
without prolonged ICU stay and hospitalization. Age was
significantly older in patients with prolonged ICU stay and
hospitalization than those without prolonged ICU stay and
hospitalization (p Z 0.03). Serum creatinine levels were
also significantly increased in patients with prolonged ICU
stay and hospitalization (p Z 0.009).
Multivariate logistic regression analyses were used to
adjust for potential confounders such as age, sex, creati-
nine level, heart failure class, and LVEF. Age was the only
factor that was still significantly correlated with prolonged
ICU stay and hospitalization (Table 4).Discussion
Although the technology and the facility of percutaneous
coronary intervention are improving dramatically, CABG
surgery is still frequently the inevitable solution for many
critically ill patients. Thus, it has becomemore important to
be able to predict the associated risk of CABG surgery for the
cardiac surgeon, the cardiologist, and families. It is as
important to understand the possible relationship between
the various clinical parameters and the possible cost-
effective benefits. Therefore, there are many different
scoring systems to assess the postoperative hospital stay,
morbidities, and mortality after cardiac surgery. However,
even with all these efforts, currently there is no gold stan-
dard to be followed [5,14]. In clinical practice, BNP and NT-
proBNP are simple laboratory tests with the results easily
reproduced and corroborated. Several investigators
demonstrated that plasma BNP and NT-proBNP concentra-
tions are good predictors for outcome of cardiac surgery
[8,15]. Eliasdottir et al. [15] showed that preoperative NT-
proBNP concentration was significantly higher in patients
with prolonged ICU stay, death within 28 postoperative days,
required inotropic agents or IABP, and new development of
postoperative renal failure. They also found a good corre-
lation between NT-proBNP and euroSCORE. However,pump coronary artery bypass surgery.
n Z 54) Off-pump (n Z 22) p
229.8 90.1  168.4 0.48
504.8 322.9  286.3 0.84
441.8 163.8  196.2 0.09
1120.8 515.8  778.6 0.51
3547.8 2312.2  1681.6 0.36
1781.8 963.8  741.9 0.11
Table 2 BNP and NT-proBNP concentrations in patients with and without clinical complications and outcomes (values are
shown as mean  SD).
Clinical end points Yes No p
Prolonged ICU stay and hospitalization (n Z 38)
Preoperative BNP 124.2  199.4 83.3  167.3 0.45
Postoperative day 1 BNP 508.2  546.6 215.6  305.0 0.01
Postoperative day 7 BNP 272.6  367.8 251.4  278.7 0.76
Preoperative NT-proBNP 812.3  1334.0 430.3  619.2 0.23
Postoperative day 1 NT-proBNP 3734.9  3530.3 2004.6  2728.5 0.03
Postoperative day 7 NT-proBNP 1425.4  1289.8 1293.2  1240.1 0.58
Major complications and poor outcomes (n Z 15)
Preoperative BNP 109.6  2 08.6 101.2  179.4 0.41
Postoperative day 1 BNP 556.1  437.8 357.5  433.7 0.74
Postoperative day 7 BNP 378.3  613.9 255.9  251.6 0.38
Preoperative NT-proBNP 1350.1  1528.5 603.3  667.4 0.14
Postoperative day 1 NT-proBNP 3677.1  3638.5 2817.1  3186.9 0.76
Postoperative day 7 NT-proBNP 2139.1  1893.4 1289.6  1614.3 0.13
Major complications and poor outcomes include new onset atrial fibrillation, ventricular tachycardia, ventricular fibrillation, require-
ment of intra-aortic balloon pump support, unscheduled cardiac readmission and late cardiac mortality within 1 year.
BNP Z B-type natriuretic peptide; ICU Z intensive care unit; SD Z standard deviation.
Risk factors and BNP in CABG 257Hutfless et al. [8] demonstrated that preoperative and peak
postoperative BNP levels were associated with prolonged
hospital stay and mortality within 1 year. However, these
two studies were not adjusted for the risk factors that could
influence the BNP level, NT-proBNP level, morbidity, and
mortality. In our study, we demonstrated that postoperative
Day 1 BNP and NT-proBNP concentrations were significantly
higher in patients with prolonged ICU stay and hospitaliza-
tion. However, the correlation became insignificant after
adjusting for age, sex, renal function, and LVEF. Advanced
age revealed good correlations with prolonged ICU stay and
hospitalization in both univariate and multivariate logistic
regression models. Interestingly, Khan et al. [16] have sug-
gested that models for predicting outcome after CABG
should be tested for potential interactions between age and
risk factors. In our previous series, we also found that older
patients had prolonged ICU stay and hospitalization
following CABG surgery [17]. Moreover, Olsen et al. [18]
recommended that cardiovascular risk prediction by NT-Table 3 Patient characteristics in prolonged intensive care uni
Variables Yes (n Z
Age, y 68.2  8.
Cr, mg/dL 1.3  0.4
LVEF, % 61.0  10
Off-pump surgery, n (%) 10 (26.3)
NYHA functional III and IV, n (%) 4 (10.5)
Male, n (%) 30 (78.9)
Preoperative BNP (pg/mL) 124.2  1
Postoperative day 1 BNP (pg/mL) 508.2  5
Postoperative day 7 BNP (pg/mL) 272.6  3
Preoperative NT-proBNP (pg/mL) 812.3  1
Postoperative day 1 NT-proBNP (pg/mL) 3734.9 
Postoperative day 7 NT-proBNP (pg/mL) 1425.4 
BNP Z B-type natriuretic peptide; Cr Z creatinine; LVEF Z left venproBNP was affected by age. Therefore, we strongly
suggest that risk factor adjustment be taken into consider-
ation when using BNP and NT-proBNP in predicting outcome
for patients who have undergone CABG surgery.
The BNP and NT-proBNP are mainly produced from the
cardiac ventricles by increased ventricular wall stress and
volume expansion. Morimoto et al [19]. showed that BNP
concentration reached its peak during the 24 hours after
surgery. They also demonstrated that peak BNP level was
correlated with cardiac index, dopamine infusion rate, and
cross-clamping time. However, the mechanism of the
elevated postoperative BNP and NT-proBNP concentrations
remains unclear. Plasma BNP concentration was found to
increase remarkably in graft failure and heart failure after
CABG surgery [7]. BNP level also was associated with
endothelin-1 concentration in failing human hearts [20]. It
is suspected that peak BNP concentrations reflect the
condition of vascular circulation after CABG surgery. It is
explained that high postoperative Day 1 BNP and NT-proBNPt stay and/or hospitalization.
38) No (n Z 38) p
3 60.3  10.4 0.03
1.1  0.3 0.009
.9 61.1  11.6 0.72
12 (31.5) 0.67
2 (5.2) 0.16
35 (92.1) 0.06
99.4 83.3  167.3 0.45
46.6 215.6  305.0 0.01
67.8 251.4  278.7 0.76
334.0 430.3  619.2 0.23
3530.3 2004.6  2728.5 0.03
1289.8 1293.2  1240.1 0.58
tricular ejection fraction; NYHA Z New York Heart Association.
Table 4 Multivariate correlation with prolonged intensive
care unit stay and hospitalization.
Variables (n Z 76) Odds ratio
(95% confidence interval)
p
Age, y 1.08 (1.01e1.16) 0.027
Cr, mg/dL 5.15 (0.92e28.72) 0.062
Postoperative
day 1 BNP, pg/mL
1.00 (1.00e1.00) 0.809
Sex, male 0.41 (0.08e2.09) 0.283
LVEF, % 1.00 (0.96e1.06) 0.809
BNPZ B-type natriuretic peptide; CrZ creatinine; LVEFZ left
ventricular ejection fraction.
258 T.-H. Chen et al.concentrations were found in the current study. However,
the high postoperative Day 1 BNP and NT-proBNP concen-
trations did not show significant correlation with prognosis
after other risk factor adjustments in the current study.
Patients had emergent conditions including cardiogenic
shock, emergent operation, severe left ventricular
dysfunction, and congestive heart failure that increased
morbidity and mortality after CABG surgery [3]. Emergent
conditions were also associated with a higher BNP concen-
tration [9]. Because elective CABG surgery was a prerequi-
site for enrollment in the current study, only 5% of patients
revealed New York Heart Association functional class III and
IV. Therefore, our preoperative BNP and NT-proBNP
concentrations were lower than those in previous studies
[8,15]. This may explain why preoperative BNP and NT-
proBNP are not significantly associated with outcomes in
the current study.
Limitations of study
The current study demonstrated that age was the most
important factor for predicting prolonged ICU stay and
hospitalization. Although BNP and NT-proBNP were used in
predicting outcomes for patients who have undergone
CABG surgery, we strongly suggest that risk factor adjust-
ment be taken into consideration. However, the small
sample size may result in statistical bias. Moreover, the
long-term prognosis is unclear due to the 1-year follow-up
period in the current study. Therefore, a large-scale study
and long-term follow-up should be performed in the future.
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